---
title: "Empagliflozin - Diabetes Mellitus, Type 2"
sidebar: mydoc_sidebar
permalink: db09038-mesh-d003924-1.html
toc: false 
---


Path ID: `DB09038_MESH_D003924_1`
{% include image.html url="images/db09038-mesh-d003924-1.png" file="db09038-mesh-d003924-1.png" alt="db09038-mesh-d003924-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C570240">MESH:C570240 </a> | empagliflozin | Drug |
| <a href="https://identifiers.org/UniProt:P31639">UniProt:P31639 </a> | Sodium/glucose cotransporter 2 | Protein |
| <a href="https://identifiers.org/GO:0035623">GO:0035623 </a> | renal glucose absorption | BiologicalProcess |
| <a href="https://identifiers.org/HP:0003074">HP:0003074 </a> | Hyperglycemia | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D003924">MESH:D003924 </a> | Diabetes Mellitus, Type 2 | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Empagliflozin | DECREASES ACTIVITY OF | Sodium/Glucose Cotransporter 2 |
| Sodium/Glucose Cotransporter 2 | POSITIVELY REGULATES | Renal Glucose Absorption |
| Renal Glucose Absorption | POSITIVELY CORRELATED WITH | Hyperglycemia |
| Hyperglycemia | MANIFESTATION OF | Diabetes Mellitus, Type 2 |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB09038#mechanism-of-action](https://go.drugbank.com/drugs/DB09038#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Empagliflozin#Mechanism_of_action](https://en.wikipedia.org/wiki/Empagliflozin#Mechanism_of_action)
  - [https://www.uniprot.org/uniprot/P31639#function](https://www.uniprot.org/uniprot/P31639#function)
  - [https://en.wikipedia.org/wiki/Type_2_diabetes](https://en.wikipedia.org/wiki/Type_2_diabetes)
